• Home
  • NEW DAY MEDICINE
  • 9 (71) 2024
  • 52 -9 (71) 2024 - Zakirov V.Z., Yuldosheva D.Kh. - DIAGNOSTIC SIGNIFICANCE OF IMMUNOLOGICAL LABORATORY MARKERS IN NON-ALCOHOLIC FATTY LIVER DISEASE IN MIDDLE-AGED AND ELDERLY PATIENTS WITH COVID-19

52 -9 (71) 2024 - Zakirov V.Z., Yuldosheva D.Kh. - DIAGNOSTIC SIGNIFICANCE OF IMMUNOLOGICAL LABORATORY MARKERS IN NON-ALCOHOLIC FATTY LIVER DISEASE IN MIDDLE-AGED AND ELDERLY PATIENTS WITH COVID-19

DIAGNOSTIC SIGNIFICANCE OF IMMUNOLOGICAL LABORATORY MARKERS IN NON-ALCOHOLIC FATTY LIVER DISEASE IN MIDDLE-AGED AND ELDERLY PATIENTS WITH COVID-19

Zakirov V.Z. - Bukhara State Medical Institute named after Abu Ali ibn Sina

Yuldosheva D.Kh. - Bukhara State Medical Institute named after Abu Ali ibn Sina

Resume

This article presents data on pro-inflammatory cytokines IL-1β and IL-6 in 178 middle-aged and elderly patients with non-alcoholic fatty liver disease who мсunderwent COVID-19. IL-1β cytokine levels were found to be statistically significantly higher in patients with COVID-19 than in patients without COVID-19. The aberrant increase in IL-1β is induced by COVID-19, whereas the IL-6 cytokine is increased independently of COVID-19, mainly as a result of non-alcoholic fatty liver disease.

Keywords. COVID-19, nonalcoholic fatty liver disease, inflammation, cytokines, interleukin

First page

285

Last page

291

For citation:Zakirov V.Z., Yuldosheva D.Kh. - DIAGNOSTIC SIGNIFICANCE OF IMMUNOLOGICAL LABORATORY MARKERS IN NON-ALCOHOLIC FATTY LIVER DISEASE IN MIDDLE-AGED AND ELDERLY PATIENTS WITH COVID-19//New Day in Medicine 9(71)2024 285-291 https://newdayworldmedicine.com/en/new_day_medicine/9-71-2024

List of References

  1. Ильченко Л.Ю., Никитин И.Г., Федоров И.Г.COVID-19 и поражение печени //Архивъ внутренней медицины. 2020;10/3(53):188-197.
  2. Гриневич В.Б., Кравчук Ю.А., Ткаченко Е.И., Першко А.М., Педь В.И., Сас Е.И., Губонина И.В., Лазебник Л.Б., Стефанюк О.В. Особенности ведения больных с гастроэнтерологической патологией в условиях пандемии COVID-19 //Экспериментальная и клиническая гастроэнтерология. 2020;4(176):3-18.
  3. Сабиров И.С., Муркамилов И.Т., Фомин В.В.Функциональное состояние печени и поджелудочной железы при COVID-19: взгляд терапевта //The Scientific Heritage. 2020;2(50):35-41.
  4. Сабиров И.С., Муркамилов И.Т., Фомин В.В. Гепатобилиарная система и новая коронавирусная инфекция (COVID-19) //The Scientific Heritage. 2020;2(49):49-58.
  5. Бакулин И.Г., Бакулина Н.В., Тихонов С.В., Винчук С.А., Декканова В.Д., Прокофьева Н.А. Патогенетические связи повреждения печени, ожирения и COVID-19 //Медицинский алфавит. 2020;30:5-10.
  6. Яковенко Э.П., Яковенко А.В., Иванов А.Н., Агафонова Н.А. Патология пищеварительного тракта и печени при COVID-19 //Экспериментальная и клиническая гастроэнтерология. 2020;4(176):19-23.
  7. Xamrayev А.А., Yuldosheva D.X., Zokirov V.Z., Muxammedova Z.R. Clinical-laboratory markers of progression of non-alcoholic fatty liver disease //American Journal of Medicine and Medical Sciences. – USA, 2021;11(5):419-425.
  8. Xamrayev А.А., Yuldosheva D.X., Шамсиева Т.Т., Хайдаров Д.Б. Diagnostic significance of molecular-genetic markers in the development of non-alcoholic fatty liver disease //Тиббиётда янги кун журнали. – Тошкент, 2022;9(47):374-381. https://newdayworldmedicine.com/en/article/1263
  9. Yuldasheva D.H. Shadjanova N.S., Oltiboyev R.O. Non-alcoholic fatty liver disease and modern medicine //Academicia an international multidisciplinary research journal //. Nov.2020;10(11):1931-1937.
  10. Yuldasheva D.H., Zokirov V.Z., G`ulomova Sh.Q. Non-alcoholic fatty liver disease: Modern view of the problem //A Multidisciplinary Peer Reviewed Journal. Dec.2020;6(12):286-292.
  11. Yuldosheva D.X. Diagnostic significance of laboratory markers, inflammatory and anti – inflammatory cytokines in the development of non-alcoholic fatty liver disease steatosis and steatohepatitis //British Medical Journal, 2022;3:26-35.
  12. Yuldosheva D.X. Prevalence of non- alcoholic fatty liver disease, clinical and laboratory markers //Eurasian journal of medical and natural sciences. Tashkent. 2022; P 94-100.
  13. Yuldosheva D.X. Reletionship to the refluxate type of the effectiveness of treatment degree of gastroesophageal reflux disease //European Journal of Research. Austria, Vienna. 2019;2:110-114.
  14. Yuldosheva D.X., Zokirov V.Z., G`ulomova Sh.Q. Non-alcoholic fatty liver: modern view of the problem //Multidisciplinary Peer reviewed journal. India. 2020;6(12):286-292.

    file

    download